Wall St. Analyst Announces Investment Opinion: Weekly Screener – Biotech Stocks Publication

NEW YORK--(BUSINESS WIRE)--

WallStAnalyst.com's (SEBI Reg. # INH200000147) (www.wallstanalyst.com) ‘Weekly Screener' looks at the performance of the global stock markets and more as China's economic woes, risks of global growth contraction and weak data from the U.S. last Friday shape sentiments. Our analysts scrutinized last week's fundamental and markets events to pinpoint the reasons behind the biotech sector's roller coaster trading. Our coverage includes the following companies: Xenoport Inc. XNPT, Merrimack Pharmaceuticals Inc. MACK, Amicus Therapeutics Inc. FOLD, Ariad Pharmaceuticals Inc. ARIA and XOMA Corporation XOMA. Visit us for your free biotech companies coverage at:

http://wallstanalyst.com/weekly-screener-biotech-05-october-2015/

Last Friday, U.S. nonfarm payroll came in below analysts' forecast for the period of September 2015. This is crucial economic data and the fact it came in lower than expected would most probably push back expectations for the Federal Reserve's first interest rate increase in nearly a decade by the end of the year. Following the report, U.S. markets saw additional volatility as investors started questioning the health of the U.S. economy. Read more from our complimentary Weekly Screener at:

http://wallstanalyst.com/weekly-screener-biotech-05-october-2015/

WallStAnalyst.com ‘In Focus' publication this Monday expands on our earlier coverage of the biotechnology sector. Biotech stocks pulled out from some of the losses recorded over the past two weeks on Friday, October 2, 2015. The NASDAQ Biotechnology Index (IBB), a popular biotech companies' benchmark, moved up 3.7%, while the SPDR S&P Biotech ETF (XBI) also gained 0.81%. Sign up now and read our free coverage, which is posted premarket from Monday to Friday on our website at:

http://wallstanalyst.com/index.php?/register/freeresearch

Disclaimer:

The information within this report is provided to its recipients for informational purposes only and shall not be used or considered as an offer or solicitation to trade or subscribe for securities or other financial instruments. The data contained within this report is based on information derived from reliable sources, but its accuracy or completeness cannot be warranted, expressly or impliedly, by WallStAnalyst.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005742/en/